According to Acumen Research and Consulting, the global biological seed treatment market size is expected to worth around US$ 2 billion by 2026 and to grow at striking CAGR around 11.2 % from 2019 to 2026.
The report provides analysis of global Biological Seed Treatment market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
The increased demand for non-chemical plants is anticipated to fuel sector development over the forecast period. A change in customer attitudes towards private hygiene and good food consumption is probable to boost product supply. product demand. Moreover, the growing population of older people is expected to further boost demand.
The use of the item in agricultural practices has increased significantly as it helps to avoid seed-borne and soil-borne infections and illnesses. Due to a reduced danger of surpassing residue boundaries and growing demand for sustainable agriculture, the item began gaining significance with respect to chemical therapy. In addition, a increasing organic farming trend is anticipated to have a direct effect on the product's market penetration.
According to the National Statistics Office, UK, the U.K. agriculture sector, It accounts for approximately 0.7% of the complete GDP. The item consists of naturally occurring active components, which protect against abiotic stress and soil-borne pathogens, and thus increase plant growth. Sustainable farming methods in emerging countries are probable to be an important constraint to business development. Limited shelf-life, particularly for seeds such as soybeans, is expected to have negative effects on product demand over the forecast period compared to other treated crop seeds.
Biotherapy is essential to viable farming, because it decreases fertilizer needs, improves immunity, and enhances the ability to absorb nutrients and to resist illnesses and pesticides. Reduced use of chemical fertilizers improves crop health and allow them to recover rapidly from abiotic stress like drought and salinity.
In order to improve business availability, industrial competitors have incorporated their manufacturing and distribution channels. Key market players operate through their manufacturing plants near raw material sources, which ultimately leads to low procurement costs for raw materials. In addition, businesses involved in the manufacturing and delivery of biologic seeds through a wide network of retailers distributed across main consumer areas in North Americas, Asia Pacific and Europe are engaged in the sale and delivery of the item.
The section of microbials is anticipated to expand by over 11% from 2019 to 2026 at a CAGR. In microbial therapy, the eradications and improvement in seeds are effected by bacteria such as Rhizobia, Bacillus, Pseudomonas and Streptomyces, and by fungi, like mycorrhizae, Penicillium bilaii, and Trichoderma harzianum. These products protect plants against drought, insects, pests and plant diseases extremely effectively.
Plants benefit from the bacteria discovered in the soil and many of them are biocontrol species damaging to pathogens. The pathogens are eradicated and many useful tasks are performed by bacteria to improve the physiological efficiency of the plant.
Some organisms such as rhizobacteria fix nitrogen, take antibiotics to destroy pathogenic substances, improve phosphorous accessibility, cause systemic opposition to plant pathogenic substances and are vital to the well being of a crop. Bacteria like Streptomyces Bacillus and Pseudomonas produce soluble phosphorus and reduce plant dependence on phosphate fertilizers.
Seeds are handled with crop extracts in botanical therapy to remove pathogen, decrease disease and boost germination speed. The technique is generally chosen because plant extracts are low price and easily available.
In 2018, the Seed Protection section retained the biggest share of the industry with about 65 percent of its income. Increased plant damage is projected to boost sector development in the coming years because of variables such as infected plants and biotic and abiotic stress. In addition, the increasing consumer inclination towards organic food is expected to increase the popularity of biological proteins.
The seed enhancement sector is expected to see significant development in the coming years. The growing use of biotreatment, which increases the development of seedling and germination, is stimulating development. It includes the use of multiple methods to enhance seed efficiency by enhancing its capacity to withstand illnesses and improving seed vigor, which in turn improves both harvest outcomes and crop quality.
For seed covering, biofungicides are crucial, as most pathogens are fungi. Various fungi trigger red seedling and black rot, reducing the germination rate, and affecting the strength of the seedling. The most prevalent fungal pathogens are Fusarium, Pythium, Phytophthora and Rhizoctonia. Biofungicides are used for coating to defeat these fungal pathogens and guarantee plant vitality.
The biological seed treatment industry was divided into soybean, wheat, cotton, maize, sunflower, vegetable plants and others. The vegetable crop type accounted for the largest income share of more than 25 percent in 2018 and is projected to expand at 12.0 percent of CAGR from 2019 to 2026. Increased use of biopesticides to treat vegetable plants, increased consumer inclination towards a healthy lifestyle, and increased demand for non-chemical food products are anticipated, over the anticipated era, to boost market growth.
At a CAGR of around 12 percent, the wheat sector is anticipated to expand in terms of income from 2019 to 2025. Sowing wheat plants are prone to illnesses such as pythium and fusarium (pungus) plant grain and Erwinia rhapontici (bacteria) purple plant infection. Biological treatment is vital to prevent these pathogens from infestation. Seedborne pathogens in soybeans are one of the major hazards to the formation of seedlings. Different illnesses of plants, such as stem blight, violet seed stain and a decrease in germination rates, are attributable to fungal pathogenic agents such as Phomopsis, Cercospora, Fusarium and Aspergillus. To prevent plants from these illnesses, Bacillus pumilus and Coniothyrium minitans are handled.
North America dominated the sector in 2018 on a regional basis with a share of 40.5% in revenues. The region is anticipated to develop from 2019 to 2026 at a CAGR of 12 percent. The increasing use of organic farming in nations such as the United States, Mexico and Canada is expected to lead the sector in the future. Canada and Mexico are the world's largest grain exporters. Farmers use biological seed treatments to safeguard the plants and plants from pathogens, pests and nematodes in order to produce significant plants.
In 2018, the organic farming industry in North America was estimated at around USD 48 billion. In the same year, there was an rise of 6% in the US and 9% in Canada in the organic food industry. In North America, more than 19,000 organic manufacturers are present, of which only 14,000 are present in the United States and 4,800 are present in Canada. Since 2004, the amount of organic manufacturers has risen by 66%.
Asia-Pacific is the fastest growing area, and over the prediction era, a CAGR of 12.7% is anticipated to accelerate. In nations like India, China, Bangladesh and Sri Lanka, powerful development in the farm industry is anticipated to boost consumer supply in the future. In addition, increasing population and increased revenue are anticipated to remain driving demand for meat and goods from agriculture.
Global Biological Seed Treatment Market, by Product
Global Biological Seed Treatment Market, by Function
Global Biological Seed Treatment Market, by Crop Type
Global Biological Seed Treatment Market, by Geography
The market research study on “Biological Seed Treatment Market Size, Share & Trends Analysis Report By Product, Function, Crop Type, By Region - Global Industry Size, Share, Trends and Forecast 2019 - 2026” offers detailed insights on global Biological Seed Treatment market segments with market dynamics and their impact. The report also covers basic technology development policies.
Key Players & Strategies
Key players such as BASF SE, Monsanto Company, Bayer CropScience, Syngenta AG and DowDuPont participate in procurement and joint projects as well as strategic partnerships aimed at promoting the advantages and exploration and growth skills of biological plant therapy throughout the world.
In March 2019, Italpollina purchased the U.S.-based Horticultural Alliance Inc., which is specialized in the manufacturing of mycorrhizal inoculants and other beneficial bacteria for the preservation of organic plants health. Syngenta AG cooperated in April 2019 with The Nature Conservancy to support the health of the soil, the preservation of habitats and the effective use of funds in the U.S., Argentina, Brazil, Kenya and China. In December 2017, BASF extended its manufacturing plant in Saint-Aubin-les-Elbeuf, France.
According to Acumen Research and Consulting, the biological seed treatment market size is anticipated to reach around US$ 2 billion in 2026.
The biological seed treatment market is anticipated to grow over 11.2% CAGR during the forecast period 2019 to 2026.
The section of microbials is anticipated to expand by over 11% from 2019 to 2026 at a CAGR.
In 2018, the Seed Protection section retained the biggest share of the industry with about 65% of its income.
The vegetable crop type accounted for the largest income share of more than 25 percent in 2018 and is projected to expand at 12.0 percent of CAGR from 2019 to 2026.
North America dominated the sector in 2018 on a regional basis with a share of 40.5% in revenues.
Asia-Pacific is the fastest growing area, and over the prediction era, a CAGR of 12.7% is anticipated to accelerate.